86 Chapter 3 43. Hirano R, Ehara H, Kujirai T, Uejima T, Takizawa Y, Sekine S, Kurumizaka H. Structural basis of RNA polymerase II transcription on the chromatosome containing linker histone H1. Nat Commun (2022) 13:7287. doi: 10.1038/s41467-022-35003-z 44. Palsson-McDermott EM, O’Neill LAJ. The Warburg effect then and now: From cancer to inflammatory diseases. BioEssays (2013) 35:965–973. doi: 10.1002/bies.201300084 45. Russo S, Kwiatkowski M, Govorukhina N, Bischoff R, Melgert BN. Meta-Inflammation and Metabolic Reprogramming of Macrophages in Diabetes and Obesity: The Importance of Metabolites. Front Immunol (2021) 12:4656. doi: 10.3389/FIMMU.2021.746151 46. Pratt JM, Simpson DM, Doherty MK, Rivers J, Gaskell SJ, Beynon RJ. Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes. Nat Protoc (2006) 1:1029–1043. doi: 10.1038/NPROT.2006.129 47. Ryan DG, O’neill LAJ. Krebs Cycle Reborn in Macrophage Immunometabolism. Annual Review of Immunology (2020) 38:289–313. doi: 10.1146/annurev-immunol-081619 48. O’Neill LAJ, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med (2016) 213:15–23. doi: 10.1084/jem.20151570 49. Liu S, Yang J, Wu Z. The Regulatory Role of α-Ketoglutarate Metabolism in Macrophages. Mediators Inflamm (2021) 2021:1–7. doi: 10.1155/2021/5577577 50. Ryu Y, Kee HJ, Sun S, Seok YM, Choi SY, Kim GR, Kee SJ, Pflieger M, Kurz T, Kim HS, et al. Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension. PLoS One (2019) 14: doi: 10.1371/JOURNAL.PONE.0213186 51. D’Urzo A, Boichenko AP, van den Bosch T, Hermans J, Dekker F, Andrisano V, Bischoff R. Sitespecific quantification of lysine acetylation in the N-terminal tail of histone H4 using a doublelabelling, targeted UHPLC MS/MS approach. Anal Bioanal Chem (2016) 408:3547–3553. doi: 10.1007/S00216-016-9431-1 52. Park C-W, Ryu K-Y. Cellular ubiquitin pool dynamics and homeostasis. BMB Rep (2014) 47:475– 482. doi: 10.5483/BMBRep.2014.47.9.128 53. Charbonneau M-E, Passalacqua KD, Hagen SE, Showalter HD, Wobus CE, O’Riordan MXD. Perturbation of ubiquitin homeostasis promotes macrophage oxidative defenses. Sci Rep (2019) 9:10245. doi: 10.1038/s41598-019-46526-9 54. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, Walsh MC, Choi Y, Shadel GS, Ghosh S. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature (2011) 472:476–480. doi: 10.1038/nature09973 55. Cockram PE, Kist M, Prakash S, Chen S-H, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ (2021) 28:591–605. doi: 10.1038/s41418020-00708-5 56. Liu Z, Wang Y, Gao T, Pan Z, Cheng H, Yang Q, Cheng Z, Guo A, Ren J, Xue Y. CPLM: a database of protein lysine modifications. Nucleic Acids Res (2014) 42:D531–D536. doi: 10.1093/NAR/ GKT1093 57. Caron C, Boyault C, Khochbin S. Regulatory cross-talk between lysine acetylation and ubiquitination: role in the control of protein stability. BioEssays (2005) 27:408–415. doi: 10.1002/bies.20210 58. Bäumer N, Tickenbrock L, Tschanter P, Lohmeyer L, Diederichs S, Bäumer S, Skryabin B v., Zhang F, Agrawal-Singh S, Köhler G, et al. Inhibitor of Cyclin-dependent Kinase (CDK) Interacting with Cyclin A1 (INCA1) Regulates Proliferation and Is Repressed by Oncogenic Signaling. Journal of Biological Chemistry (2011) 286:28210–28222. doi: 10.1074/JBC.M110.203471
RkJQdWJsaXNoZXIy MTk4NDMw